Showing 361 - 380 results of 795 for search 'declaration controller', query time: 0.09s Refine Results
  1. 361

    Physical development of adolescents with type 1 diabetes mellitus and the impact of the war in Ukraine on its impairment by Svetlana Turchina, Ganna Kosovtsova, Olga Varodova, Sergey Kalmykov, Yuliya Kalmykova

    Published 2024-07-01
    “…The study was conducted in accordance with the principles of the Declaration of Helsinki and accepted by the Committee on Bioethics and Deontology. …”
    Get full text
    Article
  2. 362

    Epigenetic agents, zebularine and valproic acid, inhibit the growth of the oral squamous cell carcinoma cell line HSC4 in vitro and in vivo by Shuhei Takahashi, Koki Yoshida, Durga Paudel, Tetsuro Morikawa, Osamu Uehara, Fumiya Harada, Dedy Ariwansa, Sarita Giri, Jun Sato, Hiroki Nagayasu, Yoshihiro Abiko

    Published 2025-07-01
    “…In vivo, a xenograft tumor formation assay was conducted using male BALB/Slc-nu nude mice, in accordance with the Basel Declaration and The ARRIVE guidelines 2.0. Tumor samples were analyzed by qRT-PCR, and qMSP. …”
    Get full text
    Article
  3. 363

    Application of Closed Incision Negative Pressure Wound Therapy in Ventral Hernia Repair Surgery Using a Polypropylene Mesh: A Randomized Clinical Trial by Petr Jelinek, Jan Hrubovcak, Radovan Hajovsky, Jan Velicka, Martin Pies

    Published 2024-09-01
    “…No significant effect of sex or smoking status on SSI was observed. The control group had a shorter mean length of hospital stay. …”
    Get full text
    Article
  4. 364

    A pharmacist-led educational and audit & feedback strategy to reduce antibiotic prescription in primary care: the AFA study by A. Soler, A. Huguet, A. Leiva, C. Vicens, F. Bejarano-Romero, E. Sempere, T. Izquierdo, M. M. Parera, R. Seco, M. Fages, A. Medina, L. Castillo-Palomares, E. López-Guerrero, B. A. Ferrer, L. Ugarriza, M. Llarena, L. Gallardo-Alfaro, AFA study investigators

    Published 2025-07-01
    “…Ethics and dissemination The study was approved by the Balearic island, Valencia and IDIAP Jordi Gol Ethical Committee, follows the Declaration of Helsinki, Good Clinical Practice guidelines, and applicable national and European regulations concerning clinical trials and data protection. …”
    Get full text
    Article
  5. 365

    High sensitivity C-reactive protein implicates heterogeneous metabolic phenotypes and severity in metabolic dysfunction associated-steatotic liver disease by Hao Wang, Junzhao Ye, Youpeng Chen, Yanhong Sun, Xiaorong Gong, Hong Deng, Zhiyong Dong, Lishu Xu, Xin Li, Bihui Zhong

    Published 2025-04-01
    “…Materials and methods This cross-sectional study included consecutive participants (ultrasound-diagnosed MASLD: 1,006, healthy controls: 582), and 175 patients received liver biopsy., with 733 and 310 patients underwent magnetic resonance imaging proton density fat fraction for liver fat content (LFC) quantification and two-dimensional shear-wave elastography liver stiffness measurements (LSM), respectively. …”
    Get full text
    Article
  6. 366

    A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local th... by Ugo De Giorgi, Martin Gleave, Brad Rosbrook, Stephen J Freedland, Qi Shen, Jennifer Sugg, Gabriel P Haas, Neal D Shore

    Published 2021-08-01
    “…Introduction Limited data from controlled clinical trials are available for men who experience biochemical recurrence after definitive therapy for prostate cancer. …”
    Get full text
    Article
  7. 367

    Peranan Notaris Dalam Kepastian Hukum Akta Kuasa Menjual Terhadap Objek Jual Beli Yang Pailitkan by Devi Eriyanti, Fully Handayani Ridwan

    Published 2022-05-01
    “… The purpose of this study is to determine the role of the Notary in the legal certainty of the power of attorney to sell the object in bankruptcy and to be able to find out the legal consequences and legal liability. Decision on Declaration of Bankruptcy The debtor by law loses his right to control and manage the assets he owns. …”
    Get full text
    Article
  8. 368

    Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial... by Jeffrey J Swigris, Toby M Maher, Tamera J Corte, Aryeh Fischer, Hong Xiao, Lisa Lancaster, Takafumi Suda, Xiaojiang Zhan, Jonathan G Goldin, Scott M Palmer, Hideaki Watanabe, Takashi Ogura, Anne Minnich, Giridhar S Tirucherai, Brandon Elpers, R Adam Smith, Edgar D Charles

    Published 2021-01-01
    “…Patients in both the IPF (n=240) and PF-ILD (n=120) cohorts will be randomised 1:1:1 to receive 30 mg or 60 mg BMS-986278, or placebo, administered orally two times per day for 26 weeks in the placebo-controlled treatment period. The primary endpoint is rate of change in per cent predicted forced vital capacity from baseline to week 26 in the IPF cohort.Ethics and dissemination This study will be conducted in accordance with Good Clinical Practice guidelines, Declaration of Helsinki principles, and local ethical and legal requirements. …”
    Get full text
    Article
  9. 369
  10. 370
  11. 371

    Engagement of Indigenous peoples in commercial tobacco reform strategies: a scoping review protocol by Andrew Waa, Raglan Maddox, El-Shadan Tautolo, Michelle Kennedy, Patricia Nez Henderson, Hershel Clark, Priscilla Nez, Penney Upton, Andrew Daniel Perusco, Sydney A. Martinez, Sierra Wilcox, Jeyasakthi Venugopal

    Published 2025-07-01
    “…Studies included in the review will be assessed against criteria for Indigenous engagement in research.Ethics and dissemination This protocol was led by Indigenous interests, needs and rights of Indigenous peoples, consistent with the United Nations Declaration on the Rights of Indigenous Peoples (UNDRIP), the WHO’s Framework Convention on Tobacco Control and ethical practice. …”
    Get full text
    Article
  12. 372
  13. 373
  14. 374

    Role of inflammation and haemostasis on aetiology and prognosis in young patients with ischaemic stroke: study protocol of the Observational Dutch Young Symptomatic StrokE study—EX... by Roy P C Kessels, Saskia Middeldorp, Ido R van den Wijngaard, Anil Tuladhar, Frank‐Erik de Leeuw, Heleen den Hertog, Renate M Arntz, Esmée Verburgt, Janneke P Spiegelenberg, Inge W M van Uden, Karlijn F de Laat, Frank G van Rooij, Anja van der Kolk, Jenneke Leentjens, Vitória Piai, Mark Roest, Bas de Laat

    Published 2025-03-01
    “…The ‘Observational Dutch Young StrokE study—Extended’ (ODYSSEY-nEXT) aims to enhance our understanding of these complex interactions through detailed phenotyping of the immune and haemostatic system and explore their relationship with long-term prognosis.Methods and analysis The ODYSSEY-nEXT is a multicentre prospective controlled cohort study of patients aged 18–50 years with a first neuroimaging-proven ischaemic stroke or transient ischaemic attack and healthy controls. …”
    Get full text
    Article
  15. 375
  16. 376

    MORPHOGENESIS OF BRANCHIOGENIC GLANDS OF THE NECK IN THE FETAL PERIOD OF ONTOGENESIS by О. Білоокий, Т. Хмара, Д. Проняєв, В. Безрук

    Published 2024-12-01
    “… Branchiogenic glands play an important role in the control of calcium and iodine levels and thus have a direct impact on muscle contraction and neurotransmission. …”
    Get full text
    Article
  17. 377
  18. 378

    PANDA study: subtyping of Parkinson’s disease – cohort study protocol by Yan Li, Rui Yang, Zihao Li, Mengfei Cai, Chentao He, Siming Rong, Ziqi Gao, Qibing Luo, Xilie Cui, Piao Zhang, Yuhu Zhang

    Published 2025-07-01
    “…The Prospective Assessments with Neuroimaging and fluid Data Analysis in PD (PANDA) study is a single-centre, longitudinal cohort study designed to explore PD heterogeneity by integrating multimodal neuroimaging, fluid biomarkers and comprehensive clinical assessments.Methods and analysis The PANDA study aims to recruit 500 PD patients and 100 healthy controls (HC) at Guangdong Provincial People’s Hospital from March 2021 to July 2026. …”
    Get full text
    Article
  19. 379

    Do deferred emergency payment programmes increase use of injury care services in Cameroon? A trauma registry analysis by Catherine Juillard, Alain Chichom Mefire, Fanny Nadia Dissak-Delon, Rasheedat Oke, Mark T Yost, Kathleen O’Connor, Kibu O Dzemo, Dennis J Zheng, Cindy S Umoh, Ariane S Christie

    Published 2025-03-01
    “…Background Injured patients in Cameroon face high out-of-pocket costs and care discrepancies based on ability to pay. Per government declaration, all Cameroonian hospitals instituted emergency payment deferral (EPD) programmes to mitigate financial barriers to emergency care. …”
    Get full text
    Article
  20. 380